|   | 
 
 | HL7 - Version 2.8 | 
 
 
 |   | 
| Seq | Description | German Interpretation | Length | C.LEN | Table | r/o/c | Rep# | Item | Data Structure | Section | 
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Set ID - RXV | O | 03318 | SI | 4.A.8.1 | |||||
| 2 | Bolus Type | 1..1 | 0917 | R | 03319 | ID | 4.A.8.2 | |||
| 3 | Bolus Dose Amount | O | 03320 | NM | 4.A.8.3 | |||||
| 4 | Bolus Dose Amount Units | 9999 | O | 03321 | CWE | 4.A.8.4 | ||||
| 5 | Bolus Dose Volume | 20= | O | 03322 | NM | 4.A.8.5 | ||||
| 6 | Bolus Dose Volume Units | 9999 | O | 03323 | CWE | 4.A.8.6 | ||||
| 7 | PCA Type | 1..2 | 0918 | R | 03324 | ID | 4.A.8.7 | |||
| 8 | PCA Dose Amount | 20= | O | 03325 | NM | 4.A.8.8 | ||||
| 9 | PCA Dose Amount Units | 9999 | O | 03326 | CWE | 4.A.8.9 | ||||
| 10 | PCA Dose Amount Volume | 20= | O | 03327 | NM | 4.A.8.10 | ||||
| 11 | PCA Dose Amount Volume Units | 9999 | O | 03328 | CWE | 4.A.8.11 | ||||
| 12 | Max Dose Amount | 20= | O | 03329 | NM | 4.A.8.12 | ||||
| 13 | Max Dose Amount Units | 9999 | O | 03330 | CWE | 4.A.8.13 | ||||
| 14 | Max Dose Amount Volume | 20= | O | 03331 | NM | 4.A.8.14 | ||||
| 15 | Max Dose Amount Volume Units | 9999 | O | 03332 | CWE | 4.A.8.15 | ||||
| 16 | Max Dose per Time | R | 03333 | CQ | 4.A.8.16 | |||||
| 17 | Lockout Interval | O | 03334 | CQ | 4.A.8.17 | |||||
| 18 | Syringe Manufacturer | O | 03339 | CWE | 4.A.8.18 | |||||
| 19 | Syringe Model Number | O | 03385 | CWE | 4.A.8.19 | |||||
| 20 | Syringe Size | 20= | C | 03386 | NM | 4.A.8.20 | ||||
| 21 | Syringe Size Units | C | 03431 | CWE | 4.A.8.21 | |||||
| 22 | Action Code | Aktionscode | 2..2 | 0206 | O | 00816 | ID | 4.A.8.22 | 
| Links to Other/Further HL7 Information | generated: Aug 07, 2023 (FO) | |||
| Health Level Seven, Int. (HQ) | HL7 Germany HL7 Europe | Frank Oemig's HL7 Site (Infos about the database) | HL7-Experts Network | |